News

Metsera, Inc.: Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025 MET-233i, a monthly, ultra-long ac ...
Lifewire on MSN2d
Apple Intelligence on Mac: The Complete Guide to Getting Started
How to Use Apple Intelligence in Mail. Apple Intelligence features in Mail include summarizing and writing tools. When you ...
ThyBlackMan on MSN3d
7 Glenn Jones Songs That Prove He’s One of R&B’s Unsung Legends.
When you talk about vocalists who truly understood the heart of R&B, Glenn Jones deserves a seat at the table. His ...
How Risquè! Ashley Cooke on Dropping ‘the f word’ in a Country Song
Actor David Hasselhoff is suffering from a major health concern as he was photographed in a wheelchair. On May 7, 2025, Page ...
D.R. Horton's Undervaluation May Trigger Rich Upside Once Macro Headwinds Ease
D.R. Horton remains undervalued, no matter the lowered FY2025 guidance and uncertain macro headwinds. Check out why I ...